CLINICAL_TRIALS
research
· 2016-01-01
Clinical Trial Update: Valproate and Levocarnitine in Children With Spinal Muscular Atrophy [Phase 3]
Summary
Phase 3 clinical trial update evaluating valproate and levocarnitine in children with spinal muscular atrophy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: All India Institute of Medical Sciences | Conditions: Spinal Muscular Atrophy | Phase 3 | Status: UNKNOWN